Collegium Pharmaceutical's market cap is currently ―. The company's EPS TTM is $1.184; its P/E ratio is 29.33; Collegium Pharmaceutical is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $1.48. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 149.75M	$ 136.71M	$ 135.55M	$ 144.77M	$ 129.62M
Gross Profit	$ 94.63M	$ 80.31M	$ 111.29M	$ 144.77M	$ -6.63M
EBIT	$ 65.99M	$ 49.55M	$ 77.12M	$ 3.87M	$ 11.76M
EBITDA	$ 102.85M	-	$ 117.64M	$ 44.44M	$ -82.22M
Net Income Common Stockholders	$ 31.94M	$ 20.63M	$ 13.01M	$ -17.43M	$ -7.20M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 310.55M	$ 304.56M	$ 325.47M	$ 269.48M	$ 173.69M
Total Assets	$ 1.14B	$ 1.18B	$ 1.21B	$ 1.21B	$ 1.17B
Total Debt	$ 674.28M	$ 718.39M	$ 762.35M	$ 806.24M	$ 709.17M
Net Debt	$ 363.74M	$ 413.82M	$ 436.88M	$ 536.76M	$ 535.49M
Total Liabilities	$ 947.88M	$ 998.71M	$ 1.01B	$ 1.03B	$ 1.17B
Stockholders Equity	$ 195.43M	$ 178.87M	$ 200.81M	$ 179.73M	$ 194.84M
Cash Flow	-
Free Cash Flow	$ 73.17M	-	$ 99.67M	$ 2.55M	-
Operating Cash Flow	$ 73.34M	$ 74.02M	$ 99.72M	$ 2.55M	-
Investing Cash Flow	$ -25.10M	$ -3.82M	$ -41.72M	$ -176.00K	-
Financing Cash Flow	$ -67.83M	$ -95.41M	$ -45.24M	$ 68.30M	-

Currency in USD

Collegium Pharmaceutical Earnings and Revenue History

Income Statement >

Collegium Pharmaceutical Debt to Assets

Balance Sheet >

Collegium Pharmaceutical Cash Flow

Cash Flow >

Collegium Pharmaceutical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing